Black Rock Inc. Cybin Inc. Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.48 - $1.11 $99,752 - $230,676	-207,817 Reduced 21.74%	748,212 $362,000
Q2 2022 Aug 12, 2022	BUY	$0.41 - $0.88 $38,635 - $82,925	94,233 Added 10.93%	956,029 $535,000
Q1 2022 May 12, 2022	BUY	$0.74 - $1.22 $10,129 - $16,700	13,689 Added 1.61%	861,796 $704,000
Q4 2021 Feb 10, 2022	BUY	$1.13 - $2.31 $958,360 - $1.96 Million	848,107 New	848,107 $1.02 Million

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.58B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.